Essen, Germany. Evonik has introduced a more environmentally friendly 25-kilogram paper bag for MetAMINO® (DL-methionine) by eliminating the plastic film layer. This change not only benefits customers with easier disposal options but also aligns with the EU’s new ‘Packaging & Packaging Waste Regulation’ (PPWR) aimed at enhancing recycling efforts.
Evonik removes plastic film layer in 25-kilogram bags for MetAMINO®, he new packaging helps conserve resources, facilitates recycling, and reduces CO2 emissions,Antwerp is Evonik’s first production site to switch to the new packaging, with others to follow.
The new packaging consists of two layers of paper and can be recycled as a pure paper bag (PAP 22) according to the EU recycling classification. For the Antwerp production site alone, this initiative will save 32 tons of polyethylene (PE) per year and reduces the packaging’s CO2 footprint by 20 percent. Intensive testing has confirmed that the high quality of MetAMINO® remains unchanged in the new packaging and that its shelf life of 36 months is unaffected.
“Product packaging plays an important role in our company’s efforts to reduce CO2 emissions and achieve a resource-conserving circular economy,” says Dr. Dirk Hoehler, responsible for the amino acid business at Evonik Animal Nutrition. “Packaging must protect the product effectively, but it should do so in the most environmentally friendly way possible.”
The packaging experts at Evonik Animal Nutrition have been working for several years on practical solutions to reduce the use of plastic in the packaging of MetAMINO® and other feed ingredients. The transition to the new bags has begun in Antwerp, with plans for the Singapore and Mobile (USA) sites to follow.
Evonik: Leading beyond chemistry
Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise. The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €15.2 billion and earnings (adjusted EBITDA) of €2.1 billion in 2024.